Global Longlife Hospital IPO vs Le Merite Exports IPO

Comparison between Global Longlife Hospital IPO and Le Merite Exports IPO.

IPO Details

Global Longlife Hospital IPO is a SME Fixed Price IPO proposed to list at BSE SME while Le Merite Exports IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Global Longlife Hospital IPO is up to ₹46.54 Cr whereas the issue size of the Le Merite Exports IPO is up to ₹45.48 Cr. The final issue price of Global Longlife Hospital IPO is ₹140.00 per share and of Le Merite Exports IPO is ₹75.00 per share.

 Global Longlife Hospital IPOLe Merite Exports IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹140.00 per share₹75.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1000 shares1600 shares
Fresh Issue Size33,24,000 shares60,64,000 shares
Fresh Issue Size (Amount)up to ₹46.54 Crup to ₹45.48 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total33,24,000 shares60,64,000 shares
Issue Size Total (Amount)up to ₹46.54 Crup to ₹45.48 Cr

IPO Timetable

Global Longlife Hospital IPO opens on Apr 21, 2022, while Le Merite Exports IPO opens on Apr 25, 2022. The closing date of Global Longlife Hospital IPO and Le Merite Exports IPO is Apr 25, 2022, and Apr 28, 2022, respectively.

 Global Longlife Hospital IPOLe Merite Exports IPO
Issue OpenApr 21, 2022Apr 25, 2022
Issue CloseApr 25, 2022Apr 28, 2022
Listing date (Tentative)May 04, 2022May 09, 2022

Financials & KPIs

Global Longlife Hospital IPO P/E ratio is 38.04, as compared to Le Merite Exports IPO P/E ratio of 11.09.

 Global Longlife Hospital IPOLe Merite Exports IPO
Financials

Company Financials (Restated Standalone)

Period Ended31 Dec 202131 Mar 202131 Mar 202031 Mar 2019
Assets40.0135.9041.9243.30
Total Income26.7432.7733.6634.69
Profit After Tax3.861.04-0.861.36
EBITDA9.376.133.476.91
NET Worth13.228.977.367.65
Reserves and Surplus9.395.534.495.35
Total Borrowing15.3715.3222.9123.55
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Dec 202131 Mar 202131 Mar 202031 Mar 2019
Assets177.0792.0256.2656.60
Total Income370.87269.13217.28180.93
Profit After Tax15.877.063.151.13
EBITDA10.446.384.37
NET Worth40.2124.3417.2914.14
Reserves and Surplus38.5022.6315.5812.43
Total Borrowing94.0254.0028.9937.63
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)81.43%99.99%
Promoter Shareholding (Post-Issue)54.29%72.74%
P/E Ratio38.0411.09
Market Cap₹147.00 Cr.₹176.11 Cr.
ROE28.99
ROCE43.03
Debt/Equity1.36
EPS₹1.48₹41.31
RoNW11.5428.99

Shares Offered

In the Global Longlife Hospital IPO Retail Individual Investors (RII) are offered 16,62,000 shares while in Le Merite Exports IPO retail investors are offered 16,62,000 shares. Qualified Institutional Buyers (QIB) are offered in Global Longlife Hospital IPO and in Le Merite Exports IPO.

 Global Longlife Hospital IPOLe Merite Exports IPO
Market Maker Reservation1,76,000 shares3,36,000 shares
NII16,62,000 shares30,32,000 shares
RII16,62,000 shares30,32,000 shares
Total33,24,000 shares60,64,000 shares

Bids Received (Subscription)

Global Longlife Hospital IPO subscribed 1.50x in total, whereas Le Merite Exports IPO subscribed 15.69x.

 Global Longlife Hospital IPOLe Merite Exports IPO
NII (times)1.60x15.27x
RII (times)1.40x16.10x
Total (times)1.50x15.69x

Compare with others

Compare: